Research Guide · Genomic Services

Genomic Biospecimens: DNA & RNA Sample Collection for NGS Studies in India

✍ By Dr. Manikanta ⏱ 13 min read

Next-generation sequencing has fundamentally changed how researchers understand disease, identify drug targets, and develop precision therapies. But behind every NGS dataset — every variant call, every expression profile, every fusion gene discovery — is a biospecimen. And the quality of that biospecimen determines whether the NGS data it yields is scientifically credible or scientifically useless. Genomic biospecimen collection for NGS studies is one of the most technically demanding areas of clinical and translational research. Unlike standard blood draws or routine tissue processing, genomic sample collection requires a precise alignment of collection method, processing timeline, storage conditions, and extraction protocol — all calibrated to the specific NGS assay the samples will be used for. This guide covers everything pharma companies, biotech organizations, and academic research teams need to know about genomic biospecimen collection for NGS studies in India — from sample type selection and collection protocols to DNA and RNA extraction standards, quality assessment, and what to look for in a genomic CRO partner. —

Why Genomic Biospecimen Quality Determines NGS Success

Next-generation sequencing is an extraordinarily sensitive technology. It can detect single nucleotide variants at allele frequencies below 1%, identify gene fusions from small biopsy fragments, and generate whole-genome profiles from nanogram quantities of input DNA. But that sensitivity is a double-edged instrument — it amplifies both signal and noise. A degraded DNA sample does not just produce weaker results; it produces misleading results. Fragmented RNA does not just reduce sequencing yield; it distorts gene expression profiles, introduces artefacts, and generates false positives that can misdirect entire research programs.

The implications for drug development are serious. A biomarker discovered from low-quality genomic biospecimens may not replicate in validation cohorts — not because the biology is wrong, but because the sample quality was inconsistent between discovery and validation. A companion diagnostic validated on FFPE-derived DNA from poorly fixed tissue may fail regulatory review because the extraction quality metrics were not documented or reproducible. In genomic research, sample quality is not a technical footnote — it is a foundational scientific variable.

What Are Genomic Biospecimens?

Genomic biospecimens are biological samples collected from human subjects specifically for the purpose of extracting and analysing nucleic acids — DNA or RNA — as part of a genomic research or diagnostic program. In the context of NGS studies, genomic biospecimens are the physical starting material from which sequencing libraries are built. The diversity of sample types used in genomic research reflects the range of clinical questions being asked and the biological material available for each study design.

• Whole blood in EDTA tubes — for germline DNA analysis, whole genome sequencing, and targeted gene panels
• PAXgene RNA tubes — for gene expression profiling and transcriptomic studies, preserving RNA from whole blood at room temperature
• Peripheral Blood Mononuclear Cells (PBMCs) — for immune cell-specific transcriptomics and single-cell RNA sequencing
• Formalin Fixed Paraffin Embedded (FFPE) tissue blocks — for somatic mutation analysis, tumour profiling, and archival genomic studies
• Fresh-frozen tissue — for high-quality RNA extraction and comprehensive transcriptomic analysis
• Buccal swabs — for germline DNA in population genomics and pharmacogenomics studies
• Cell-free DNA (cfDNA) / Circulating Tumour DNA (ctDNA) — from plasma, for liquid biopsy and minimal residual disease monitoring
• Urine — for non-invasive ctDNA detection in bladder and urological cancers

DNA vs RNA — Understanding the Difference for NGS

The distinction between DNA and RNA collection fundamentally shapes every aspect of your biospecimen protocol — collection tube selection, processing timelines, storage conditions, and extraction methodology. Understanding these differences is essential for designing a genomic biospecimen collection program that will yield NGS-ready samples.

DNA Biospecimens for NGS

DNA is a relatively stable molecule. Whole blood collected in EDTA tubes for germline DNA analysis can be stored at 4°C for up to 72 hours before extraction without significant degradation. FFPE-derived DNA, while fragmented by the fixation process, is stable at room temperature for decades in properly stored blocks. DNA NGS applications include whole genome sequencing (WGS), whole exome sequencing (WES), targeted gene panels (oncology, pharmacogenomics, rare disease), copy number variation analysis, and somatic mutation profiling.

RNA Biospecimens for NGS

RNA is inherently unstable. It begins degrading from the moment of collection — enzymatic RNases present in blood and tissue actively destroy RNA within minutes at room temperature if samples are not properly stabilised. RNA NGS applications include gene expression profiling, RNA-seq for transcriptomic analysis, fusion gene detection, and single-cell RNA sequencing. For RNA studies, collection tube selection is critical — PAXgene RNA tubes contain a proprietary reagent that immediately lyses cells and stabilises RNA, enabling room temperature storage for up to 72 hours post-collection.

Step #1: Selecting the Right Sample Type for Your NGS Study

The first decision in any genomic biospecimen program is matching the sample type to the specific NGS assay and scientific question. This is not a one-size-fits-all decision — the optimal sample type depends on whether you are studying germline or somatic variants, whether you need tumour-specific data or systemic immune response, and whether you require fresh material or can work with archival samples.

Step #2: Collection Protocol — What Happens at the Site

The collection site is where genomic biospecimen quality is made or lost. Even the most sophisticated extraction laboratory cannot recover quality from a sample that was poorly collected, stored incorrectly on-site, or shipped without temperature control. A rigorous site-level collection protocol is the foundation of any genomic biospecimen program.

Blood Collection for Genomic Studies

For whole blood genomic DNA collection, EDTA tubes are standard. The collection procedure itself is straightforward — but the handling immediately after collection is where errors typically occur. Tubes must be inverted 8–10 times immediately after collection to ensure adequate mixing with the anticoagulant, stored at 4°C (not frozen) if processing is delayed beyond 4 hours, and processed within 72 hours of collection to maintain DNA integrity. For PAXgene RNA tubes, immediate inversion is critical — 10 inversions within 60 seconds of collection — and the tube must then be stored at room temperature for 2 hours before refrigeration or freezing.

Tissue Biospecimen Collection for NGS

For fresh-frozen tissue intended for RNA-seq or high-quality DNA extraction, the time from surgical excision to snap-freezing is the most critical variable. Tissue should be snap-frozen in liquid nitrogen within 30 minutes of resection — ideally within 15 minutes for RNA-sensitive applications. Delays beyond 30 minutes result in progressive RNA degradation that cannot be reversed at any subsequent processing step. This requires pre-positioning of liquid nitrogen dewars at the surgical suite — a logistical coordination that must be established during site initiation, not improvised on the day of collection.

Clinical site blood collection for genomic NGS study — PAXgene RNA tube inversion protocol India

Step #3: DNA and RNA Extraction — Quality Standards That Matter

Nucleic acid extraction is the bridge between the biological sample and the NGS library. The extraction method must be matched to both the sample type and the downstream NGS application — a method optimised for high-molecular-weight germline DNA from blood is not appropriate for fragmenting FFPE-derived DNA, and an RNA extraction kit validated for PAXgene tubes may not perform optimally on fresh-frozen tissue of high fat content.

DNA Extraction Standards for NGS

For whole blood DNA destined for WGS or WES, extraction should yield high-molecular-weight DNA with minimal fragmentation — A260/280 ratios between 1.8 and 2.0 indicate good purity, free from protein and RNA contamination. For FFPE-derived DNA, specialised FFPE DNA extraction kits are required — these use elevated proteinase K digestion temperatures and extended incubation times to reverse formalin cross-linking and maximise yield from fragmented material. Yield requirements vary by panel: targeted oncology panels may require as little as 10–20ng input DNA, while WES typically requires 100–250ng.

RNA Extraction Standards for NGS

RNA quality is assessed primarily through the RNA Integrity Number (RIN) — a score from 1 to 10 generated by capillary electrophoresis, where 10 represents completely intact RNA and 1 represents fully degraded material. For comprehensive RNA-seq, a RIN of 7 or above is generally required. For highly degraded FFPE-derived RNA, DV200 (the percentage of RNA fragments above 200 nucleotides) is used instead — a DV200 above 30% is typically the minimum threshold for FFPE RNA NGS applications.

• A260/280 ratio 1.8–2.0: DNA purity acceptable for NGS
• A260/230 ratio greater than 1.8: Absence of organic solvent contamination
• RIN greater than or equal to 7: RNA integrity sufficient for RNA-seq
• DV200 greater than 30%: Minimum FFPE RNA quality for NGS library preparation
• DNA fragment size greater than 500bp: Adequate for most targeted panels from FFPE
• Yield minimum 10ng: Minimum input for targeted oncology panels

Step #4: Quality Assessment Before NGS Library Preparation

No genomic biospecimen should proceed to NGS library preparation without a documented quality assessment. This quality gate protects both the scientific integrity of the study and the sponsor’s investment — a failed library preparation from a low-quality sample wastes NGS sequencing capacity, delays timelines, and may require subject re-contact for re-collection, which is not always possible.

Standard QC Workflow

A complete pre-library QC workflow includes quantification by fluorometric methods (Qubit or PicoGreen — spectrophotometric methods like NanoDrop alone are insufficient because they cannot distinguish DNA from RNA or nucleotide contamination), integrity assessment by capillary electrophoresis (Bioanalyzer or TapeStation for RIN/DV200), and fragment size distribution analysis for FFPE samples. Results are compared against pre-defined acceptance criteria specified in the study protocol — samples failing QC are flagged, root cause is investigated, and re-collection is arranged where feasible.

DNA RNA extraction quality assessment Bioanalyzer TapeStation NGS library preparation India

Step #5: Storage, Cold Chain, and International Shipment

Genomic biospecimens have stringent storage requirements that must be maintained from the moment of extraction through to delivery to the analytical laboratory — whether that laboratory is in Bengaluru or Boston. Temperature excursions during storage or transit are one of the most common causes of sample quality failure in multi-site genomic studies, and they are almost entirely preventable with the right infrastructure and logistics protocols.

Storage Conditions by Sample Type

Extracted DNA for long-term storage should be stored at -80°C in low-binding tubes at concentrations of 20–100ng/µL in TE buffer (10mM Tris-HCl, 1mM EDTA, pH 8.0) — storage in water accelerates DNA hydrolysis over time. Extracted RNA requires -80°C storage and should be aliquoted to avoid repeated freeze-thaw cycles, each of which degrades RNA quality measurably. FFPE blocks are stable at room temperature in dark, dry conditions — but extracted FFPE DNA and RNA must be stored at -80°C. PAXgene RNA tubes can be stored at -20°C or -80°C after the initial 2-hour room temperature incubation.

International Shipment of Genomic Biospecimens

For genomic biospecimens being shipped from India to international analytical laboratories, IATA P650 packaging compliance is mandatory for all human-derived biological samples. Extracted DNA shipped on dry ice must be packed in validated UN3373 packaging with certified dry ice quantities adequate for the transit duration plus a 24-hour buffer. RNA samples require dry ice shipment with pre-arranged recipient confirmation to ensure immediate storage on arrival. Complete export documentation — commercial invoice, packing list, Material Transfer Agreement, and CITES/biological import permit if required by the destination country — must accompany every international shipment.

Why India Is a Strategic Choice for Genomic Biospecimen Collection

India’s unique combination of patient population diversity, established genomic research infrastructure, and internationally accredited CRO ecosystem makes it one of the most strategically valuable locations for genomic biospecimen collection programs globally.

Genetic Diversity Unmatched in Western Populations

India’s 1.4 billion population encompasses extraordinary genetic diversity — across hundreds of ancestral lineages, geographic isolates, and admixed urban populations. For pharmacogenomics studies examining drug metabolism gene variants, for oncology programs characterising mutation profiles in Indian patient populations, and for population genomics programs requiring representation of South Asian ancestry groups, India provides access to a patient pool with genetic characteristics that simply cannot be replicated through collection in the US or Europe. This diversity is increasingly recognised as scientifically essential as the field moves toward globally inclusive precision medicine.

Cost Advantage at Scale

Genomic biospecimen collection and processing in India costs approximately 35–40% less than equivalent operations in the US or Europe — at ISO and NABL accredited facilities operating to the same international quality standards. For large-scale genomic programs requiring thousands of samples across multiple timepoints, this cost advantage translates directly to a larger, more statistically powered study for the same research budget.

How Biospecimen Solutions Supports Your NGS Study End-to-End

Biospecimen Solutions Private Ltd. is an ISO 9001 certified and NABL accredited CRO based in Bengaluru, with validated workflows for genomic biospecimen collection across all major sample types used in NGS research — from whole blood DNA and PAXgene RNA to FFPE tissue, fresh-frozen tissue, and liquid biopsy cfDNA/ctDNA.

• Validated collection SOPs for whole blood DNA, PAXgene RNA, PBMC, FFPE, fresh-frozen tissue, and cfDNA
• BSL-2 and BSL-3 certified laboratory infrastructure for processing and extraction
• Automated DNA and RNA extraction with Qubit quantification and Bioanalyzer QC
• -80°C and liquid nitrogen (-196°C) storage with 24/7 temperature monitoring
• 100,000+ FFPE blocks available for retrospective genomic studies
• AI-powered LIMS tracking with full chain of custody documentation
• IATA P650 compliant international genomic sample shipment to 25+ countries
• Dedicated Project Manager for every genomic study
• ICH GCP and GLP compliant operations throughout